Literature DB >> 7909875

Completeness of reporting trial results: effect on physicians' willingness to prescribe.

M Bobbio1, B Demichelis, G Giustetto.   

Abstract

Clinical trials may lead to conflicting results. We studied how different ways of reporting results affected physicians' recommendations. A questionnaire distributed to 148 general practitioners presented results of a clinical trial where a reduction of cardiac events and an increase of mortality was reported. Results were shown in four different ways--relative risk reduction, absolute risk reduction, percentages of event-free patients, number needing to be treated to prevent an event--as if they derived from different trials. A fifth presentation was the reduced rate of cardiac events along with the increased rate of mortality. Physicians were asked to estimate how much they would be willing to prescribe each drug. The mean agreement of physicians' decisions was 77 (28)% for relative risk reduction, 24 (28)% for absolute risk reduction, 37 (37)% for different percentages event-free patients, 34 (34)% for number need to treat, and 23 (28)% for events reduction and mortality for increase (p < 0.001 relative risk vs others). The method of reporting trial results and the completeness of information in the case of controversial results affects physicians willingness to prescribe.

Entities:  

Keywords:  Biomedical and Behavioral Research; Empirical Approach; Professional Patient Relationship

Mesh:

Year:  1994        PMID: 7909875     DOI: 10.1016/s0140-6736(94)92407-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  41 in total

Review 1.  The effects of information framing on the practices of physicians.

Authors:  P McGettigan; K Sly; D O'Connell; S Hill; D Henry
Journal:  J Gen Intern Med       Date:  1999-10       Impact factor: 5.128

2.  Reporting of numerical and statistical differences in abstracts: improving but not optimal.

Authors:  Eric Dryver; Janet E Hux
Journal:  J Gen Intern Med       Date:  2002-03       Impact factor: 5.128

3.  How patient outcomes are reported in drug advertisements.

Authors:  J Lexchin
Journal:  Can Fam Physician       Date:  1999-05       Impact factor: 3.275

Review 4.  Risk communication in the patient-health professional relationship.

Authors:  S Buetow; J Cantrill; B Sibbald
Journal:  Health Care Anal       Date:  1998-09

5.  Drugs in the news: an analysis of Canadian newspaper coverage of new prescription drugs.

Authors:  Alan Cassels; Merrilee A Hughes; Carol Cole; Barbara Mintzes; Joel Lexchin; James P McCormack
Journal:  CMAJ       Date:  2003-04-29       Impact factor: 8.262

6.  Bridging the gap between therapeutic research results and physician prescribing decisions: knowledge transfer, a prerequisite to knowledge translation.

Authors:  Jean-Pierre Boissel; Emmanuel Amsallem; Michel Cucherat; Patrice Nony; Margaret C Haugh
Journal:  Eur J Clin Pharmacol       Date:  2004-09-16       Impact factor: 2.953

7.  CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials.

Authors:  David Moher; Sally Hopewell; Kenneth F Schulz; Victor Montori; Peter C Gøtzsche; P J Devereaux; Diana Elbourne; Matthias Egger; Douglas G Altman
Journal:  BMJ       Date:  2010-03-23

8.  Health professionals: how do they assess new medicines?

Authors:  Rebecca Cheng; Kirsty Cook; Sarah Dowman; Rebecca Lawn; Jemma Leary; Taryn Quinn; Kim Schroder; Nicola Smith; June Tordoff
Journal:  Pharm World Sci       Date:  2005-06

9.  A randomized comparison of patients' understanding of number needed to treat and other common risk reduction formats.

Authors:  Stacey L Sheridan; Michael P Pignone; Carmen L Lewis
Journal:  J Gen Intern Med       Date:  2003-11       Impact factor: 5.128

10.  A proposal for an additional clinical trial outcome measure assessing preventive effect as delay of events.

Authors:  Per Lytsy; Lars Berglund; Johan Sundström
Journal:  Eur J Epidemiol       Date:  2012-12-07       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.